118 related articles for article (PubMed ID: 17352676)
1. The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?
Godinho R; Mega C; Teixeira-de-Lemos E; Carvalho E; Teixeira F; Fernandes R; Reis F
J Diabetes Res; 2015; 2015():806979. PubMed ID: 26075286
[TBL] [Abstract][Full Text] [Related]
2. A physiologic and pharmacological basis for implementation of incretin hormones in the treatment of type 2 diabetes mellitus.
Freeman JS
Mayo Clin Proc; 2010 Dec; 85(12 Suppl):S5-S14. PubMed ID: 21106868
[TBL] [Abstract][Full Text] [Related]
3. Tackling dipeptidyl peptidase IV in neurological disorders.
Al-Badri G; Leggio GM; Musumeci G; Marzagalli R; Drago F; Castorina A
Neural Regen Res; 2018 Jan; 13(1):26-34. PubMed ID: 29451201
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies.
Schwartz S; Kohl BA
Diabetes Metab Syndr Obes; 2010 Jul; 3():227-42. PubMed ID: 21437091
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes.
Shaikh S; Lee EJ; Ahmad K; Ahmad SS; Lim JH; Choi I
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34203048
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus: new challenges and innovative therapies.
Sena CM; Bento CF; Pereira P; Seiça R
EPMA J; 2010 Mar; 1(1):138-63. PubMed ID: 23199048
[TBL] [Abstract][Full Text] [Related]
7. Novel Agents for the Treatment of Type 2 Diabetes.
DeFronzo RA; Triplitt CL; Abdul-Ghani M; Cersosimo E
Diabetes Spectr; 2014 May; 27(2):100-12. PubMed ID: 26246766
[TBL] [Abstract][Full Text] [Related]
8. Reflections on the state of diabetes research and prospects for treatment.
Accili D; Du W; Kitamoto T; Kuo T; McKimpson W; Miyachi Y; Mukhanova M; Son J; Wang L; Watanabe H
Diabetol Int; 2023 Jan; 14(1):21-31. PubMed ID: 36636157
[TBL] [Abstract][Full Text] [Related]
9. Ligand-based designing of DPP-4 inhibitors via hybridization; synthesis, docking, and biological evaluation of pyridazine-acetohydrazides.
Nidhar M; Kumar V; Mahapatra A; Gupta P; Yadav BK; Singh RK; Tewari AK
Mol Divers; 2023 Dec; 27(6):2729-2740. PubMed ID: 36534357
[TBL] [Abstract][Full Text] [Related]
10. Tombul hazelnut (
Çağlar AF; Göksu AG; Çakır B; Gülseren İ
Food Chem X; 2021 Dec; 12():100151. PubMed ID: 34888520
[TBL] [Abstract][Full Text] [Related]
11. Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.
Wilcox T; De Block C; Schwartzbard AZ; Newman JD
J Am Coll Cardiol; 2020 Apr; 75(16):1956-1974. PubMed ID: 32327107
[TBL] [Abstract][Full Text] [Related]
12. [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Lepr
Samad MB; Mohsin MNAB; Razu BA; Hossain MT; Mahzabeen S; Unnoor N; Muna IA; Akhter F; Kabir AU; Hannan JMA
BMC Complement Altern Med; 2017 Aug; 17(1):395. PubMed ID: 28793909
[TBL] [Abstract][Full Text] [Related]
13. Gold Nanoparticle-Based Colorimetric and Electrochemical Methods for Dipeptidyl Peptidase-IV Activity Assay and Inhibitor Screening.
Xia N; Wang X; Wang X; Zhou B
Materials (Basel); 2016 Oct; 9(10):. PubMed ID: 28773977
[TBL] [Abstract][Full Text] [Related]
14. Interaction potential of Carmegliptin with P-glycoprotein (Pgp) transporter in healthy volunteers.
Kuhlmann O; Carlile D; Noe J; Bentley D
J Drug Assess; 2014; 3(1):28-37. PubMed ID: 27536451
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines as DPP-4 Inhibitors.
Kaczanowska K; Wiesmüller KH; Schaffner AP
ACS Med Chem Lett; 2010 Dec; 1(9):530-5. PubMed ID: 24900243
[TBL] [Abstract][Full Text] [Related]
16. Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus.
Shubrook J; Colucci R; Guo A; Schwartz F
Clin Med Insights Endocrinol Diabetes; 2011; 4():1-12. PubMed ID: 22879789
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.
Richter B; Bandeira-Echtler E; Bergerhoff K; Lerch CL
Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD006739. PubMed ID: 18425967
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type 2 diabetes.
Sebokova E; Christ AD; Boehringer M; Mizrahi J
Curr Top Med Chem; 2007; 7(6):547-55. PubMed ID: 17352676
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase IV inhibitors and diabetes therapy.
McIntosh CH
Front Biosci; 2008 Jan; 13():1753-73. PubMed ID: 17981665
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
